Liu, Xinyan
Barreto, Erin F.
Dong, Yue
Liu, Chang
Gao, Xiaolan
Tootooni, Mohammad Samie
Song, Xuan
Kashani, Kianoush B. https://orcid.org/0000-0003-2184-3683
Funding for this research was provided by:
Center for Individualized Medicine, Mayo Clinic (J011972)
Article History
Received: 17 July 2022
Accepted: 31 July 2023
First Online: 11 August 2023
Declarations
:
: This study was deemed exempt by the institutional review board of Mayo Clinic, Rochester, MN (#19–010472). All participants provided verbal consent to contribute to the interview. The Mayo Clinic, Institutional Review Board, agreed to obtain verbal instead of oral contrast as the study carried minimal risk based on the assessment of the IRB. The verbal consent script (provided as supplementary material) was read to the participants, and they only entered the interviews when they agreed with the content of the verbal consent. Therefore, pharmacists who rejected the verbal consent (all pharmacists who were approached agreed to contribute) did not participate in the study.
: Not applicable.
: None of the authors had any conflict of interest.